ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0181

Magnetic Resonance Imaging Findings in Early Rheumatoid Arthritis: Are There Differences Based on Autoantibody Status?

Caitrin Coffey1, Gavin McKenzie1, Nicholas Rhodes1, Cassondra Hulshizer1, Cynthia Crowson2, John Davis1 and Kerry Wright1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

Meeting: ACR Convergence 2021

Keywords: Anti-CCP, Autoantibody(ies), Imaging, Magnetic resonance imaging (MRI), rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Magnetic resonance imaging (MRI) is increasingly used as an adjunct to the physical examination in early rheumatoid arthritis (RA). Characteristic differences in MRI findings between patients with early seropositive and seronegative RA have not previously been described. We aimed to determine whether hand and/or wrist MRI findings differed between patients with incident RA based on autoantibody status.

Methods: Patients with incident RA from a population-based cohort between 1999-2014 who fulfilled either the 1987 or 2010 ACR/EULAR classification criteria for RA were retrospectively reviewed. Patients who underwent MRI of the hand and/or wrist within ± 1 year of fulfillment of the earlier of 1987 or 2010 classification criteria as part of their routine clinical care were identified using Current Procedural Terminology (CPT) codes. Studies were confirmed via manual chart review. MRI images were reviewed and scored according to the Outcome Measures in Rheumatology Clinical Trials (OMERACT) RA MRI scoring system (RAMRIS), by an experienced musculoskeletal radiologist blinded to patients’ clinical data. Studies with incomplete images or artifact precluding scoring were excluded at the radiologist’s discretion. Serial studies of the ipsilateral hand or wrist were excluded for each patient. RAMRIS scores were compared between seronegative (RF-, CCP-) and seropositive (RF+ and/or CCP+) patients using generalized linear models, with random intercepts to account for multiple studies per patient.

Results: 86 patients with a total of 137 MRI studies of the hand and/or wrist were included for RAMRIS scoring. RF and/or CCP were negative in 53 (62%) of patients. Patients were 71% female, mean age 54.7 (SD 12.5) years, 95% white, 19% current smokers with no significant differences between groups.

57 total hand studies were scored. Mean total hand RAMRIS score was 7.4 (SD 5.1) for seropositive and 8.9 (SD 6.3) for seronegative patients. Mean synovitis, bone erosions, and bone marrow edema scores were comparable between groups (Table).

55 total wrist studies were scored. Mean total wrist RAMRIS score was 9.8 (SD 13.9) for seropositive and 7.8 (SD 6.1) for seronegative patients. Mean total wrist bone marrow edema score was 7.3 (SD 11.3) for seropositive and 2.4 (SD 3.2) for seronegative patients. Mean synovitis and bone erosions scores were comparable between groups (Table).

Estimates using generalized linear models showed that wrist bone marrow edema scores were on average 4.9 RAMRIS units higher in seropositive vs seronegative patients (p=0.014). There was a trend toward higher hand bone marrow edema scores in seronegative vs seropositive patients by 1.07 RAMRIS units that did not reach significance (p=0.067). Other mean RAMRIS scores did not differ significantly between groups.

Conclusion: RAMRIS scores for MRIs of the hands and wrists performed as part of routine clinical care for patients with early, incident RA varied widely. Mean wrist bone marrow edema score was significantly higher in seropositive vs seronegative patients, though mean total RAMRIS scores, synovitis scores, and bone erosions scores did not differ significantly based upon autoantibody status.

*SD = standard deviation; **IQR = interquartile range


Disclosures: C. Coffey, None; G. McKenzie, None; N. Rhodes, None; C. Hulshizer, None; C. Crowson, None; J. Davis, Pfizer, 5; K. Wright, None.

To cite this abstract in AMA style:

Coffey C, McKenzie G, Rhodes N, Hulshizer C, Crowson C, Davis J, Wright K. Magnetic Resonance Imaging Findings in Early Rheumatoid Arthritis: Are There Differences Based on Autoantibody Status? [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/magnetic-resonance-imaging-findings-in-early-rheumatoid-arthritis-are-there-differences-based-on-autoantibody-status/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/magnetic-resonance-imaging-findings-in-early-rheumatoid-arthritis-are-there-differences-based-on-autoantibody-status/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology